腎泌尿器外科学

Medicine & Life Sciences

1. 2-amino-6-chloro-9-((5-dihydroxyboryl)pentyl)purine 13%
2. abiraterone 30%
3. Abiraterone Acetate 10%
4. Albumins 18%
5. Allografts 41%
6. Androgens 18%
7. Anti-Bacterial Agents 10%
8. Antibodies 26%
9. Autism Spectrum Disorder 12%
10. Biopsy 14%
11. Brachytherapy 19%
12. Brain Death 52%
13. Bronchiolitis Obliterans 10%
14. C-Reactive Protein 19%
15. cabazitaxel 18%
16. Cadaver 11%
17. Carcinoma 24%
18. Castration 52%
19. Cerebrospinal Fluid 10%
20. Cicatrix 12%
21. Cyclosporine 18%
22. Cystectomy 16%
23. Delayed Graft Function 45%
24. dicarboxydine 11%
25. Docetaxel 17%
26. Drug Therapy 11%
27. Flavoxate 11%
28. Gene Expression Profiling 14%
29. Genes 11%
30. Graft Survival 43%
31. Groin 10%
32. HLA Antigens 13%
33. Immunoglobulin G 12%
34. Immunotherapy 11%
35. Infections 16%
36. Islets of Langerhans Transplantation 18%
37. Isografts 26%
38. Japan 73%
39. Kidney 100%
40. Kidney Neoplasms 17%
41. Kidney Transplantation 87%
42. Lipocalin-2 32%
43. Living Donors 11%
44. Lung Transplantation 10%
45. Lymph Nodes 22%
46. Lymphocytes 11%
47. Margins of Excision 14%
48. MDV 3100 20%
49. Molecular Targeted Therapy 24%
50. Multicenter Studies 27%
51. Multivariate Analysis 11%
52. Neoplasm Metastasis 26%
53. Neoplasms 43%
54. Nephrectomy 57%
55. Nephroureterectomy 31%
56. Nivolumab 17%
57. Nocturia 16%
58. Nutritional Status 11%
59. Pancreas 14%
60. Pancreas Transplantation 39%
61. Pelvic Neoplasms 12%
62. Progression-Free Survival 19%
63. Propensity Score 20%
64. Prostate 52%
65. Prostate-Specific Antigen 32%
66. Prostatectomy 27%
67. Prostatic Hyperplasia 13%
68. Prostatic Neoplasms 71%
69. Pyelonephritis 11%
70. Pyonephrosis 13%
71. Recovery of Function 12%
72. Recurrence 18%
73. Renal Cell Carcinoma 76%
74. Renal Dialysis 14%
75. Robotics 20%
76. SCID Mice 22%
77. Seeds 20%
78. Seminoma 11%
79. Serum 20%
80. Sonazoid 10%
81. Sunitinib 12%
82. Surgeons 11%
83. Survival 47%
84. Survival Rate 16%
85. Swine 16%
86. Therapeutics 22%
87. Tissue Donors 95%
88. Tomography 10%
89. Transplant Recipients 22%
90. Transplantation 25%
91. Transplants 84%
92. Type 1 Diabetes Mellitus 11%
93. Ureter 22%
94. Urinary Bladder 12%
95. Urinary Tract 17%
96. Urinary Tract Infections 20%
97. Urination 10%
98. Urine 13%
99. Volatilization 16%
100. Warm Ischemia 22%